10.1111/j.1365-2362.2011.02609.x 151
Scientists study peptides like BPC-157 Peptide Nasal Spray, B7-33, and TB500 for their potential to support tissue recovery and help regulate inflammatory responses
Only increase if weight loss stalls for 3 or more consecutive weeks, appetite suppression fades before your next injection, or your prescriber recommends escalation based on your individual progress
Why it was included in the FDA ban The FDA cites significant safety risks due to the potential for congestive heart failure in certain patients seen in a clinical trial that was terminated
The healing and anti-inflammatory properties of BPC-157 in lab animals are thought to work in the same way in humans
Sources: Neelakantan H, Brightwell CR, Graber TG, et al